[174 Pages Report] The global Orthopedic Imaging Equipment Market was valued at US$ 9.8 Billion in 2021 and is expected to reach US$ 14.6 Billion by 2031. The increasing number of accidents and sports injuries resulting in fractures and bone injuries is boosting the need for orthopedic diagnostic imaging.
| Data Points | Market Insights |
|---|---|
| Orthopedic Imaging Equipment Market Value 2020 | US$ 9.3 Billion |
| Orthopedic Imaging Equipment Market Market Value 2031 | US$ 14.6 Billion |
| CAGR 2021 to 2031 | 4.0% |
| Share of Top 5 Countries | 58.6% |
| Key Players | General Electric Healthcare Limited; Siemens AG; Esaote SPA; Hitachi Ltd; Koninklijke Philips N.V; PLANMED OY; EOS imaging |
Imaging technologies such as magnetic resonance imaging (MRI), computed tomography (CT or CAT), and ultrasound have opened new therapy possibilities with little morbidity. The increasing prevalence of orthopedic diseases such as osteoporosis, arthritis, elbow pain, and others have increased the demand for diagnosis and diagnostic equipment across the globe.
According to the Centers for Disease Control and Prevention (CDC), in The USA, around 72 million people will be affected by arthritis by 2030. Against this backdrop, demand for orthopedic imaging equipment is expected to bolster in the USA, making it one of the most lucrative pockets in the global market.
The orthopedic imaging equipment market holds nearly 31% of the medical imaging equipment market, totaling US$ 29.5 Billion by the end of 2031. There have been significant developments in medical imaging technology and orthopedic imaging equipment devices.
Subsequently, increased rates of bone disease and accidents resulting in bone injuries are driving the need for effective orthopedic diagnostic imaging.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 4.84% |
| H1, 2022 Projected | 3.94% |
| H1, 2022 Outlook | 3.64% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 30 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 120 ↓ |
The global orthopaedic imaging equipment market is subject to devise regulations, product patents, licensing requirements, and quality and safety assessment, as per all the macro and industry standards.
The key developments in the market include the development of advanced 3D imaging and software modelling of the target imaging field. The market is highly influenced by the growing adoption of portable or hand-held imaging devices, and the utilization of predictive modelling to identify surgical interventional sites for enhanced patient compliance with treatment.
The H1-2022 outlook period in comparison to H1-2022 projected period showed negative growth in terms of Basis Point Share by 30 BPS. And in H1-2022, the market growth rate of orthopaedic imaging equipment is expected to fall by 120 basis point shares (BPS), as per FMI analysis
The market decline observed through the reduction in the BPS values is addressed by the risk of radiation exposure during imaging, lack of qualified professional workforce to operate advanced imaging modalities, and high initial equipment cost followed by subsequently high maintenance costs.
According to Future Market Insights, sales of orthopedic imaging equipment grew at a CAGR of 4.0% between 2016 and 2020. With the rising incidence of orthopedic diseases and bone injuries coupled with a growing geriatric population, sales are expected to reach US$ 14.6 Billion by the end of 2031.
According to a UN report, the geriatric population will increase from 9.3 % in 2020 to around 16% in 2050. This increase in population will result in more acute and chronic injuries. Hence, demand for orthopedic imaging equipment is expected to increase, boosting the market.
Additionally, the global prevalence of osteoarthritis (OA) is rapidly increasing. Also, there has been a noticeable increase in the obesity ratio across the globe. Being overweight increases the pressure exerted on joints such as the knee, causing tension and speeding up cartilage breakdown.
Hence, the risk of bone and chronic injuries is expected to accelerate over the coming years. This is expected to create growth opportunities for the orthopedic imaging equipment market players.
Consequently, there is also a significant shift in doctors’ preference towards innovative and advanced technologies such as advanced MRI and CT imaging techniques. Development in these techniques will result in increased demand in the market.
Further, the orthopedic imaging equipment market is expected to grow with the expansion of the healthcare industry and the surging need to discover novel technologies to effectively diagnose any issue.
Rising acceptance and quick expansion of new technologies, especially in emerging economies such as India and China will boost the market throughout the forecast period. Hence, leading companies are concentrating on introducing new products as well as research and development.
Considering this, FMI expects the global orthopedic imaging equipment market to expand at over a CAGR of 5.4%, in terms of volume, through 2021.
Currently, several developing and underdeveloped nations are lacking adequate imaging infrastructure to conduct tests and technology implementation. Developed nations such as the USA have better diagnostic imaging and use advanced imaging techniques.
However, with few reimbursement policies and a lack of healthcare infrastructure, the market in underdeveloped economies in Latin America is expected to witness headwinds in the upcoming years.
These economies lack widespread access to diagnostic imaging, limiting the sales in the orthopedic imaging equipment market.
Besides this, the high cost involved in the initial setup and installation of imaging equipment and broadband technology in remote locations might hamper the growth of the global orthopedic imaging equipment market.
Additionally, the chances of recovering the costs solely depend on the number of scans arriving per day. Hence, achieving break-even is quite uncertain and entails high risk. This is expected to be the major restraining factor in the orthopedic imaging equipment market.
Principal Consultant
In 2021, the USA is expected to account for about 89.2% of the North American orthopedic imaging equipment market. Growing incidence of arthritis, acute injuries, increasing geriatric population, and high per capita healthcare spending in the USA are some of the factors boosting the market.
Furthermore, government funding for the procurement of imaging equipment by various institutions in the USA will aid the expansion of the market.
As per FMI, the UK is expected to account for 13.1% of the Europe market by 2021. Growth in the country is attributable to the technological advancements in medical devices used in orthopedic imaging and favorable government policies.
As per the National Health Service (UK), more than ten million individuals suffer from arthritis or other joint-related diseases. The rising prevalence of such bone diseases will improve the demand for orthopedic imaging equipment and treatment, accelerating sales in the UK.
China is projected to witness growth at a 6.9% CAGR in East Asia throughout the forecast period, opines Future Market Insights.
The increasing geriatric population and growing prevalence of osteoarthritis and other bone diseases are propelling the growth of China's orthopedic imaging equipment market.
According to the World Health Organization (WHO), by 2040, the geriatric population is expected to grow by 28% in China.
Demand for orthopedic imaging equipment in India is expected to rise at an impressive 6.3% CAGR over the forecast period, finds Future Market Insights.
Increasing research and development activities, rapid growth in medical device technology, and increasing adoption of medical devices are aiding the growth of the orthopedic imaging equipment market in India.
By product, the X-ray system segment is anticipated to hold the maximum share of 28.0 % in 2021. The segment is expected to exhibit growth at 3.3% CAGR during the forecast period.
The demand for X-rays is expected to outpace the sales of other imaging equipment, owing to several advantages of X-rays such as easy availability, accessibility, and cost-effectiveness.
They are more accessible than MRI and can be used to identify injuries and masses within the body more quickly. X-rays are one of the most cost-effective and widely used imaging techniques across developing economies such as India and China.
In terms of indication, the acute injuries segment is projected to dominate the market. As per FMI, the segment is expected to account for 56.6% of the total market share in 2021.
Growth in the segment is underpinned by an increase in accidental cases, sports injuries, and bone dislocation across the globe. According to the research study on acute injuries, over 30 million children participate in organized sports activities, among them nearly 3.5 million undergo severe acute injuries.
More than 775,000 children are treated in hospital emergency rooms for such injuries, resulting in the need for advanced orthopedic imaging equipment.
In terms of end-user, hospitals, and radiology centers, collectively, hold over 60% of the market share in 2021 and this trend is expected to continue during the forecast period as well.
A growing number of standalone imaging centers is propelling the growth in the radiology centers segment. Also, independent imaging centers provide discounts in order to attract more people, aiding the growth of the segment.
In addition, the time it takes for patients to have an MRI or other imaging procedure in radiology centers is reduced. Hence, the adoption of orthopedic imaging equipment will increase in radiology centers.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Companies in the orthopedic imaging equipment market are pursuing new product innovations and launches, regulatory approvals, and expansion of their product portfolios as key strategies.
Key players are also focusing on the development of advanced and cost-effective products establishing distribution agreements to expand their global footprints, especially in Asia Pacific.
Moreover, companies are targeting Indian and China markets by establishing manufacturing units in order to reduce manufacturing costs. For instance:
| Attribute | Details |
|---|---|
| Forecast Period | 2021 to 2031 |
| Historical Data Available for | 2016 to 2020 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia and Pacific; East Asia; and Middle East & Africa (MEA) |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, Germany, The UK, France, Italy, Spain, Benelux, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Thailand, Indonesia, Australia, and New Zealand, Egypt, Turkey, South Africa, North Africa, and GCC Countries |
| Key Segments Covered | Product, Indication, End User, and Region |
| Key Companies Profiled | General Electric Healthcare Limited; Siemens AG; Esaote SPA; Hitachi Ltd; Koninklijke Philips N.V; Planmed OY; EOS imaging; Canon Medical Systems Corporation; Neusoft Corporation; Carestream Health |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
By Product:
By Indication:
By End-User:
By Region:
The global orthopedic imaging equipment market is worth US$ 9.8 Billion in 2021 and is set to expand by 1.5X over the next ten years.
The orthopedic imaging equipment market is expected to reach US$ 14.6 Billion, with sales increasing at a 4.0% CAGR by the end of 2031.
Sales in the orthopedic imaging equipment market are expected to increase owing to the rising government and private body initiatives and surging demand for 3D medical imaging equipment.
North America currently holds the largest market share in the orthopedic imaging equipment market globally. The region is expected to contribute over 30.5% of the sales in the orthopedic imaging equipment market. As per FMI, the USA is expected to spearhead the growth, surpassing US$ 2.5 Billion in 2021.
Japan’s market for orthopedic imaging equipment is expected to exhibit healthy growth at 4.3% CAGR during the forecast period.
The USA, Russia, Poland, China, and Japan are the top 5 countries driving the demand in the orthopedic imaging equipment market.
1. Executive Summary | Orthopaedic Imaging Equipment Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Technological Roadmap
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Key Development Trends
3.3. New Launches / Approvals
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Healthcare Expenditure Outlook
4.1.3. Emerging Countries Healthcare and Development Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Adoption of Device Product
4.2.2. Prevalence of Orthopaedic Disorders
4.2.3. Historical growth of key players
4.2.4. New product launches and approvals
4.2.5. COVID-19 Impact
4.2.6. Reimbursement scenario
4.2.7. Expansion by Leading Manufacturer in Emerging Geographies
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. Market Context
5.1. List of Manufacturers and Suppliers
5.2. Usage/ Adoption Analysis
5.3. Promotional Strategies by Key Manufacturer
5.4. Technological Advancements
5.5. Regulatory Scenario
5.6. Porter’s Analysis
5.7. PESTLE Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as Compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Product
6.4.2. Revenue By Indication
6.4.3. Revenue By End User
6.4.4. Revenue By Region
6.5. 2021 Market Scenario
7. Global Market Volume (Units) Analysis 2016 to 2020 and Forecast, 2021 to 2031
7.1. Historical Market Volume (Units) Analysis, 2016 to 2020
7.2. Current and Future Market Volume (Units) Projections, 2021 to 2031
7.2.1. Y-o-Y Growth Trend Analysis
8. Market -Pricing Analysis
8.1. Regional Pricing Analysis By Indication
8.2. Pricing Break-up
8.2.1. Manufacturer-Level Pricing
8.2.2. Distributor Level Pricing
8.3. Average Pricing Analysis Benchmark
9. Global Market Value (US$ Million) Analysis 2016 to 2020 and Forecast, 2021 to 2031
9.1. Historical Market Value (US$ Million) Analysis, 2016 to 2020
9.2. Current and Future Market Value (US$ Million) Projections, 2021 to 2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Product, 2016 to 2020
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2021 to 2031
10.3.1. X-Ray Systems
10.3.2. CT-Scanner
10.3.3. Orthopaedic Imaging Equipment
10.3.4. EOS Imaging Systems
10.3.5. Ultrasound
10.3.6. Nuclear Imaging Systems
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis, By Indication, 2016 to 2020
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2021 to 2031
11.3.1. Acute injuries
11.3.1.1. Sports injuries
11.3.1.2. Trauma cases
11.3.2. Chronic Disorders
11.3.2.1. Osteoarthritis
11.3.2.2. Osteoporosis
11.3.2.3. Prolapsed Disc
11.3.2.4. Degenerative joint diseases
11.3.3. Market Attractiveness Analysis By Indication
12. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By End User, 2016 to 2020
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2021 to 2031
12.3.1. Hospitals
12.3.2. Radiology Centers
12.3.3. Emergency Care Facility
12.3.4. Ambulatory Surgical Centres
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2016 to 2020
13.3. Current Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2021 to 2031
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
14.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
14.3.1. By Country
14.3.1.1. The USA
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Indication
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Latin America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
15.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Indication
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Europe Market Analysis 2016 to 2020 and Forecast 2021 to 2031
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
16.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
16.3.1. By Country
16.3.1.1. The UK
16.3.1.2. Germany
16.3.1.3. France
16.3.1.4. Italy
16.3.1.5. Spain
16.3.1.6. Russia
16.3.1.7. BENELUX
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Indication
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
17.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Indication
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
18.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.1.4. Rest of East Asia
18.3.2. By Product
18.3.3. By Indication
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Oceania Market Analysis 2016 to 2020 and Forecast 2021 to 2031
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
19.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Indication
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market Analysis 2016 to 2020 and Forecast 2021 to 2031
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020
20.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. Northern Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Indication
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
21. Countries Level Market Analysis 2021 & 2031
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.1.3. Pricing Analysis
21.2. The USA Market Analysis
21.2.1. By Product
21.2.2. By Indication
21.2.3. By End User
21.3. Canada Market Analysis
21.3.1. By Product
21.3.2. By Indication
21.3.3. By End User
21.4. Mexico Market Analysis
21.4.1. By Product
21.4.2. By Indication
21.4.3. By End User
21.5. Brazil Market Analysis
21.5.1. By Product
21.5.2. By Indication
21.5.3. By End User
21.6. The UK Market Analysis
21.6.1. By Product
21.6.2. By Indication
21.6.3. By End User
21.7. Germany Market Analysis
21.7.1. By Product
21.7.2. By Indication
21.7.3. By End User
21.8. France Market Analysis
21.8.1. By Product
21.8.2. By Indication
21.8.3. By End User
21.9. Italy Market Analysis
21.9.1. By Product
21.9.2. By Indication
21.9.3. By End User
21.10. Spain Market Analysis
21.10.1. By Product
21.10.2. By Indication
21.10.3. By End User
21.11. BENELUX Market Analysis
21.11.1. By Product
21.11.2. By Indication
21.11.3. By End User
21.12. Russia Market Analysis
21.12.1. By Product
21.12.2. By Indication
21.12.3. By End User
21.13. China Market Analysis
21.13.1. By Product
21.13.2. By Indication
21.13.3. By End User
21.14. Japan Market Analysis
21.14.1. By Product
21.14.2. By Indication
21.14.3. By End User
21.15. South Korea Market Analysis
21.15.1. By Product
21.15.2. By Indication
21.15.3. By End User
21.16. India Market Analysis
21.16.1. By Product
21.16.2. By Indication
21.16.3. By End User
21.17. Indonesia Market Analysis
21.17.1. By Product
21.17.2. By Indication
21.17.3. By End User
21.18. Thailand Market Analysis
21.18.1. By Product
21.18.2. By Indication
21.18.3. By End User
21.19. Malaysia Market Analysis
21.19.1. By Product
21.19.2. By Indication
21.19.3. By End User
21.20. Australia Market Analysis
21.20.1. By Product
21.20.2. By Indication
21.20.3. By End User
21.21. New Zealand Market Analysis
21.21.1. By Product
21.21.2. By Indication
21.21.3. By End User
21.22. GCC Countries Market Analysis
21.22.1. By Product
21.22.2. By Indication
21.22.3. By End User
21.23. Turkey Market Analysis
21.23.1. By Product
21.23.2. By Indication
21.23.3. By End User
21.24. South Africa Market Analysis
21.24.1. By Product
21.24.2. By Indication
21.24.3. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Share Analysis of Top Players
22.3. Market Concentration
22.4. Market Presence Analysis
22.4.1. By Regional Footprint of Players
22.4.2. Product foot print by Players
22.4.3. Channel foot print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
23.3.1. GE Healthcare
23.3.1.1. Overview
23.3.1.2. Product Portfolio
23.3.1.3. Analyst Commentary
23.3.1.4. Key Financials
23.3.1.5. Recent Developments
23.3.1.6. Profitability by Market Segments (Product / Channel / Region)
23.3.1.7. Sales Footprint
23.3.1.8. Strategy Overview
23.3.1.8.1. Marketing Strategy
23.3.1.8.2. Product Strategy
23.3.1.8.3. Channel Strategy
23.3.2. Koninklijke Philips N.V.
23.3.2.1. Overview
23.3.2.2. Product Portfolio
23.3.2.3. Analyst Commentary
23.3.2.4. Key Financials
23.3.2.5. Recent Developments
23.3.2.6. Profitability by Market Segments (Product / Channel / Region)
23.3.2.7. Sales Footprint
23.3.2.8. Strategy Overview
23.3.2.8.1. Marketing Strategy
23.3.2.8.2. Product Strategy
23.3.2.8.3. Channel Strategy
23.3.3. Siemens Healthineers
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Analyst Commentary
23.3.3.4. Key Financials
23.3.3.5. Recent Developments
23.3.3.6. Profitability by Market Segments (Product / Channel / Region)
23.3.3.7. Sales Footprint
23.3.3.8. Strategy Overview
23.3.3.8.1. Marketing Strategy
23.3.3.8.2. Product Strategy
23.3.3.8.3. Channel Strategy
23.3.4. Esaote SPA
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Analyst Commentary
23.3.4.4. Key Financials
23.3.4.5. Recent Developments
23.3.4.6. Profitability by Market Segments (Product / Channel / Region)
23.3.4.7. Sales Footprint
23.3.4.8. Strategy Overview
23.3.4.8.1. Marketing Strategy
23.3.4.8.2. Product Strategy
23.3.4.8.3. Channel Strategy
23.3.5. Canon Medical Systems, Inc.,
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Analyst Commentary
23.3.5.4. Key Financials
23.3.5.5. Recent Developments
23.3.5.6. Profitability by Market Segments (Product / Channel / Region)
23.3.5.7. Sales Footprint
23.3.5.8. Strategy Overview
23.3.5.8.1. Marketing Strategy
23.3.5.8.2. Product Strategy
23.3.5.8.3. Channel Strategy
23.3.6. Hitachi Medical Systems
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Analyst Commentary
23.3.6.4. Key Financials
23.3.6.5. Recent Developments
23.3.6.6. Profitability by Market Segments (Product / Channel / Region)
23.3.6.7. Sales Footprint
23.3.6.8. Strategy Overview
23.3.6.8.1. Marketing Strategy
23.3.6.8.2. Product Strategy
23.3.6.8.3. Channel Strategy
23.3.7. PLANMED OY
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Analyst Commentary
23.3.7.4. Key Financials
23.3.7.5. Recent Developments
23.3.7.6. Profitability by Market Segments (Product / Channel / Region)
23.3.7.7. Sales Footprint
23.3.7.8. Strategy Overview
23.3.7.8.1. Marketing Strategy
23.3.7.8.2. Product Strategy
23.3.7.8.3. Channel Strategy
23.3.8. EOS imaging
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Analyst Commentary
23.3.8.4. Key Financials
23.3.8.5. Recent Developments
23.3.8.6. Profitability by Market Segments (Product / Channel / Region)
23.3.8.7. Sales Footprint
23.3.8.8. Strategy Overview
23.3.8.8.1. Marketing Strategy
23.3.8.8.2. Product Strategy
23.3.8.8.3. Channel Strategy
23.3.9. Neusoft Corporation
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Analyst Commentary
23.3.9.4. Key Financials
23.3.9.5. Recent Developments
23.3.9.6. Profitability by Market Segments (Product / Channel / Region)
23.3.9.7. Sales Footprint
23.3.9.8. Strategy Overview
23.3.9.8.1. Marketing Strategy
23.3.9.8.2. Product Strategy
23.3.9.8.3. Channel Strategy
23.3.10. Carestream Health
23.3.10.1. Overview
23.3.10.2. Product Portfolio
23.3.10.3. Analyst Commentary
23.3.10.4. Key Financials
23.3.10.5. Recent Developments
23.3.10.6. Profitability by Market Segments (Product / Channel / Region)
23.3.10.7. Sales Footprint
23.3.10.8. Strategy Overview
23.3.10.8.1. Marketing Strategy
23.3.10.8.2. Product Strategy
23.3.10.8.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Explore Healthcare Insights
View Reports
Orthopaedic Imaging Equipment Market
